Forma Therapeutics gets European orphan drug status for FT-4202 to treat sickle cell disease

This article was originally published here

SCD, which is a common single-gene disorder, is estimated to affect over 70,000 in the EU-27 and up to 100,000 people in the US. The status was provided

The post Forma Therapeutics gets European orphan drug status for FT-4202 to treat sickle cell disease appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply